Both in Biotechnology
Acumen Pharmaceuticals vs Pluri
Over the past year ABOS returned −89.2% and PLUR returned −65.8%; their daily moves had a correlation of -0.02.
ABOS −89.2% PLUR −65.8%Growth of $1, one year, split-adjusted
| Metric | ABOS | PLUR |
|---|---|---|
| Price | $0.2102 | $1.21 |
| Market cap | $15.2M | $16.4M |
| Today | −2.82% | −1.63% |
| 1 month | −90.0% | +16.3% |
| 6 months | −91.5% | −63.8% |
| Year to date | −90.0% | −59.5% |
| 1 year | −89.2% | — |
| Revenue growth (YoY) | — | −15.8% |
| Gross margin | — | 58.5% |
| Net margin | — | −1755.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 16.1× |
| Net cash | $52.3M | -$23.9M |
| Dividend yield | — | — |
| Volatility (60d) | 492.8% | 80.1% |
| Short % of float | 7.6% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).